Jury says AstraZeneca should pay Pfizer $107M+ over Tagrisso infringement
A federal jury in Delaware determined that AstraZeneca infringed two Pfizer patents with its blockbuster cancer treatment Tagrisso, and that the British drugmaker should pay $107.5 million as a result. The patents in question cover …